Physician profile
Joanne K Simpson
NPI 1184746455
$4,876.93
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,571 · 2020: $690 · 2021: $341 · 2022: $1,682 · 2023: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,132.47 | 2019-2023 | Skyrizi, Rinvoq |
| Pfizer INC. | $571.65 | 2019-2023 | |
| Lilly USA, LLC | $459.66 | 2019-2023 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $392.70 | 2019-2023 | Ilumya |
| Galderma Laboratories, L.P. | $387.60 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $345.60 | 2019-2022 | |
| Medimetriks Pharmaceuticals, INC. | $277.94 | 2021-2023 | |
| Janssen Biotech, INC. | $250.00 | 2019-2020 | |
| Ucb, INC. | $220.48 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $132.98 | 2023 | Dupixent |
| Janssen Scientific Affairs, LLC | $103.32 | 2020 | |
| Almirall LLC | $81.97 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $65.89 | 2020-2021 | |
| Sandoz INC. | $51.20 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $43.43 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $42.14 | 2022-2023 | Vtama |
| Leo Pharma INC. | $42.06 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $40.65 | 2020-2021 | |
| Genzyme Corporation | $40.36 | 2020-2022 | |
| Aclaris Therapeutics, INC. | $36.32 | 2019 | |
| Epi Health, LLC | $32.65 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.24 | 2019 | |
| Journey Medical Corporation | $16.99 | 2022 | |
| Hologic Sales and Service, LLC | $16.72 | 2020 | |
| Prugen, INC. Pharmaceuticals | $15.95 | 2019 | |
| Allergan, INC. | $15.71 | 2019 | |
| Arcutis Biotherapeutics, INC. | $14.75 | 2023 | |
| Sebela Pharmaceuticals INC. | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.